Choice and interpretation of statistical tests used when competing risks are present.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
James J Dignam, Maria N Kocherginsky

Abstract

In clinical cancer research, competing risks are frequently encountered. For example, individuals undergoing treatment for surgically resectable disease may experience recurrence near the removed tumor, metastatic recurrence at other sites, occurrence of second primary cancer, or death resulting from noncancer causes before any of these events. Two quantities, the cause-specific hazard function and the cumulative incidence function, are commonly used to summarize outcomes by event type. Tests for event-specific differences between treatment groups may thus be based on comparison of (a) cause-specific hazards via a log-rank or related test, or (b) the cumulative incidence functions via one of several available tests. Inferential results for tests based on these different metrics can differ considerably for the same cause-specific end point. Depending on the questions of principal interest, one or both metrics may be appropriate to consider. We present simulation study results and discuss examples from cancer clinical trials to illustrate these points and provide guidance for analysis when competing risks are present.

References

Jan 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·A Tsiatis
Apr 1, 1992·Statistics in Medicine·E L Korn, F J Dorey
Mar 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R GelmanJ R Harris
Jul 30, 1994·International Journal of Radiation Oncology, Biology, Physics·R J CaplanJ D Cox
Jul 30, 1995·International Journal of Radiation Oncology, Biology, Physics·S M BentzenJ Overgaard
Nov 1, 1996·International Journal of Radiation Oncology, Biology, Physics·R Chappell
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R T ChlebowskiD G Pfister
Oct 31, 2002·Statistics in Medicine·Melania Pintilie
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy E SmithUNKNOWN National Surgical Adjuvant Breast and Bowel Project Experience
Aug 12, 2004·British Journal of Cancer·J M SatagopanA D Auerbach
Feb 12, 2005·Statistics in Medicine·Boris Freidlin, Edward L Korn
Jan 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·A V Peterson
Apr 26, 2006·Biostatistics·Jong-Hyeon Jeong, Jason P Fine
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Haesook T Kim
Oct 24, 2007·Statistics in Medicine·A Latouche, R Porcher

❮ Previous
Next ❯

Citations

Sep 27, 2012·Lifetime Data Analysis·Bernhard HallerKurt Ulm
Oct 19, 2013·Oral Oncology·Kaveh ZakeriLoren K Mell
Mar 15, 2013·Bone Marrow Transplantation·Simona Iacobelli, UNKNOWN EBMT Statistical Committee
Nov 16, 2011·Prostate Cancer and Prostatic Diseases·S ShikanovS E Eggener
Nov 10, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C H RyuS Y Kim
Jan 26, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A J Olszewski, J J Castillo
Feb 22, 2013·Journal of the National Cancer Institute·Michael GnantKathleen I Pritchard
Jan 28, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·David W EvansChristian Verger
Jan 28, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James J DignamMasha Kocherginsky
May 27, 2011·BMC Medical Research Methodology·Aurélien BelotRoch Giorgi
Jun 7, 2011·BMC Medical Research Methodology·Arthur AllignolJan Beyersmann
May 28, 2013·BMC Nephrology·Laetitia TeixeiraDenisa Mendonça
Sep 15, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann A LazarRichard D Gelber
Apr 23, 2011·AJR. American Journal of Roentgenology·Constantinos T SofocleousStephen B Solomon
Jun 3, 2014·BMC Medical Research Methodology·Federico Rotolo, Stefan Michiels
Nov 2, 2014·BMC Musculoskeletal Disorders·Jeff Chien-Fu LinTsai-Hsueh Leu
Apr 24, 2013·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·M EsslerN Andratschke
Sep 8, 2010·American Journal of Epidemiology·Nadine GrambauerJan Beyersmann
Feb 26, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Volker AssfalgUwe Heemann
Mar 15, 2016·International Journal of Radiation Oncology, Biology, Physics·Julie KjemsJeppe Friborg
Aug 17, 2010·International Journal of Radiation Oncology, Biology, Physics·Michael D HasselleLoren K Mell
Mar 27, 2010·Computer Methods and Programs in Biomedicine·Thomas FilleronAndrew Kramar
Aug 26, 2010·Cancer·Loren K MellSteven J Chmura
Mar 26, 2015·Clinical Orthopaedics and Related Research·Sarah LacnyDeborah A Marshall
Sep 19, 2015·International Journal of Radiation Oncology, Biology, Physics·Hidenori Inohara
Jul 2, 2015·International Journal of Radiation Oncology, Biology, Physics·Daniel R SimpsonCatheryn M Yashar
Jul 8, 2015·BMC Nephrology·Jeff Chien-Fu Lin, Wen-Miin Liang
Nov 1, 2012·Journal of Hepatology·Eduardo Vilar GomezLuis Perez Blanco
Apr 4, 2015·International Journal of Radiation Oncology, Biology, Physics·Hidenori InoharaKazuhiko Ogawa
Mar 16, 2013·The Breast : Official Journal of the European Society of Mastology·Yazan MigdadyAdam J Olszewski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Loren K Mell, Jong-Hyeon Jeong
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
James J DignamMasha Kocherginsky
© 2022 Meta ULC. All rights reserved